Epilepsy and Seizures Clinical Presentation
- Author: Jose E Cavazos, MD, PhD, FAAN; Chief Editor: Selim R Benbadis, MD more...
History
The diagnosis of epileptic seizures is made by analyzing the patient's detailed clinical history and by performing ancillary tests for confirmation. Someone who has observed the patient's repeated events is usually the best person to provide an accurate history. However, the patient also provides invaluable details about auras, preservation of consciousness, and postictal states. A key feature of epileptic seizures is their stereotypic nature.
Questions that help clarify the type of seizure include the following:
- Was any warning noted before the spell? If so, what kind of warning occurred?
- What did the patient do during the spell?
- Was the patient able to relate to the environment during the spell and/or does the patient have recollection of the spell?
- How did the patient feel after the spell? How long did it take for the patient to get back to baseline condition?
- How long did the spell last?
- How frequent do the spells occur?
- Are any precipitants associated with the spells?
- Has the patient shown any response to therapy for the spells?
Physical Examination
The clinical diagnosis of seizures is based on the history obtained from the patient and, most important, the observers. Physical examination helps in the diagnosis of specific epileptic syndromes that cause abnormal findings, such as dermatologic abnormalities. For example, patients with intractable generalized tonic-clonic seizures for years are likely to have injuries requiring stitches.
Overview of Epileptic Seizures Classification
In 1981, the International League Against Epilepsy (ILAE) developed an international classification of epileptic seizures that divides seizures into 2 major classes: partial-onset seizures and generalized-onset seizures. Partial-onset seizures begin in a focal area of the cerebral cortex, whereas generalized-onset seizures have an onset recorded simultaneously in both cerebral hemispheres. Some seizures are difficult to fit into a single class, and they are considered unclassified seizures. This classification is still widely accepted.
Other classifications, such as the semiologic classification advanced by Luders and others, have been proposed.[11] A refinement of this semiologic classification led to a 5-dimensional (5-D) patient-oriented classification of epilepsy.[12] The ILAE commission on classification has developed additional reports.[13, 14] In 2006, a new proposed classification of seizures was published.[13, 14] The 2 main changes in this classification are (1) the use of focal rather than partial and (2) the proposal that a single seizure in the setting of a predisposition for further seizures be considered epilepsy. In 2010, the ILAE commission on classification explained in more detail the decision of using the changes in terminology.[15]
Focal-Onset Seizures
Focal-onset seizures are further classified as simple focal seizures, complex focal seizures, or secondarily generalized tonic-clonic seizures.
Simple and complex focal seizures
The defining element of simple focal seizures is a seizure with preserved consciousness. Many patients with complex focal seizures have an aura warning them of their seizure. An aura is a simple focal seizure. The many kinds of simple focal seizures include sensory, motor, autonomic, and psychic types. Any discrete experience that involves the cerebral cortex could be a simple focal-onset seizure. The diagnosis is based on the repeated, stereotypic occurrence of the same experience in association with focal electroencephalographic (EEG) changes or on recurrent auras leading to a complex focal-onset seizure or a secondarily generalized seizure. Resolution of the recurrent clinical phenomena with anticonvulsants is presumptive but not diagnostic evidence for epileptic seizures.
The clinical diagnosis is difficult, as many stereotypic auras may be induced in areas of the cerebral cortex that are not recorded well on a typical EEG. About 20-40% of auras have an ictal correlate on the scalp EEG. Simple focal seizures may last a few seconds to a few minutes. However, if the aura lasts longer than 30 minutes, it is considered simple focal status epilepticus by definition.
Consciousness is impaired during a complex focal seizure. In practice, assessing the patient's history to determine whether consciousness was impaired is difficult. The most common way to assess preserved consciousness is asking patients if they remembered the event. Patients might be able to remember their aura but are unaware that they were briefly unable to respond to the environment.
A complex focal seizure typically begins with behavioral arrest and is followed by staring, automatisms, and postictal confusion. Automatisms frequently consist of chewing, lip smacking, mumbling, and fumbling with the hands. Dystonic posturing of the contralateral upper extremity is often seen when a complex partial seizure originates from the mesial temporal lobe. A typical complex focal seizure lasts about 60-90 seconds and is followed by brief postictal confusion. However, generalized weakness, asthenia, and fatigue may last for a few days.
Complex focal seizures of frontal-lobe origin may feature bizarre motor behaviors such as bicycling or a fencing posture. They have more prominent motor features than those of complex focal seizures of temporal-lobe onset. Frontal lobe onset complex focal seizures may have a fast postictal recovery to baseline, and they often appear in clusters of seizures. The great majority of complex focal seizures have an ictal correlate on the EEG. A normal alpha rhythm during behavioral impairment of consciousness is highly suggestive of nonepileptic seizures.
Secondarily generalized seizures
Secondarily generalized seizures often begin with an aura that evolves into a complex focal seizure and then into a generalized tonic-clonic seizure. However, a complex focal seizure may evolve into a generalized tonic-clonic seizure, or an aura may evolve into a generalized tonic-clonic seizure without an obvious complex focal seizure. Clinically classifying a generalized tonic-clonic seizure as being secondarily generalized (focal onset) or primarily generalized is difficult on the basis of the history alone. In most cases, the association with prominent amnesia for the aura increases with the severity of a secondarily generalized seizure.
Generalized-Onset Seizures
Generalized-onset seizures are classified into 6 major categories, as follows:
- Absence seizures
- Myoclonic seizures
- Clonic seizures
- Tonic seizures
- Primary generalized tonic-clonic seizures
- Atonic seizures
Each seizure type is classified by its clinical and EEG manifestations. On occasion, classifying seizures is difficult despite videotape review of the data.
Absence seizures
Absence seizures are brief episodes of impaired consciousness with no aura or postictal confusion. They typically last less than 20 seconds and are accompanied by few or no automatisms. Facial automatisms are most common, and repetitive blinking is the most common facial automatism. Hyperventilation or photic stimulation often precipitates these seizures which typically begin during childhood or adolescence, although they may persist into adulthood.
A diagnosis of new-onset absence seizures in adulthood is incorrect in the vast majority of cases. Adults often have complex focal seizures with relatively minor automatisms. In children, absence seizures are often unrecognized until a child develops a generalized tonic-clonic seizure, and then the child is brought to medical attention. Sudden decreased performance in school or overall attention might be a subtle manifestation of frequent absence seizures.
The classic ictal electroencephalogram (EEG) correlate of absence seizures consists of 3.5-Hz generalized spike-and–slow wave complexes. Twin studies have demonstrated a significant inherited predisposition for typical childhood absence seizures. EEG abnormalities may persist into adulthood despite the absence of clinical seizures. However, compared with the EEG discharges in children, those in adults occur less often, they are less well formed, and they are of lesser amplitude.
Myoclonic, clonic, and tonic seizures
Myoclonic seizures consist of brief, arrhythmic, jerking, motor movements that last less than 1 second. Myoclonic seizures often cluster within a few minutes. If they evolve into rhythmic, jerking movements, they are classified as evolving into a clonic seizure. Myoclonus is not always epileptic in origin. For example, the myoclonic jerks during phase I of sleep are normal release phenomena. The classic ictal correlate of myoclonic seizures in the EEG consists of fast polyspike-and–slow wave complexes.
Clonic seizures consist of rhythmic, motor, jerking movements with or without impairment of consciousness. Clonic seizures can have a focal origin with or without impaired consciousness. The focal seizures are classified as simple or complex partial seizures. The typical generalized clonic seizures simultaneously involve the upper and lower extremities. The ictal EEG correlate consists of bilateral rhythmic epileptiform discharges.
Tonic seizures consist of sudden-onset tonic extension or flexion of the head, trunk, and/or extremities for several seconds. These seizures typically occur in relation to drowsiness, shortly after the person falls asleep, or just after he or she awakens. They are often associated with other neurologic abnormalities. The ictal correlate of tonic seizures in the EEG includes an electrodecremental response, which is a high-frequency electrographic discharge in the beta frequency (also known as "beta buzz") with a relatively low amplitude compared with that of the background rhythm. This pattern may evolve into slow spike-and-wave complexes or diffuse polyspikes.
Primary generalized tonic-clonic seizures
Tonic-clonic seizures are commonly referred to as grand mal seizures. They consist of several motor behaviors, including generalized tonic extension of the extremities lasting for few seconds followed by clonic rhythmic movements and prolonged postictal confusion. On clinical evaluation, the only behavioral difference between these seizures and secondarily generalized tonic-clonic seizures is that these seizures lack an aura. However, the aura preceding the secondarily generalized seizure is often forgotten because of postictal amnesia.
The ictal correlate of generalized tonic-clonic seizures consists of generalized (bilateral) complexes of spikes or polyspike and slow waves. These epileptiform discharges often have increased amplitude in the frontal regions.
Atonic seizures
Atonic seizures occur in people with clinically significant neurologic abnormalities. These seizures consist of brief loss of postural tone, often resulting in falls and injuries. The ictal EEG correlate is similar to abnormalities observed in tonic seizures.
Classification of Epileptic Syndromes
Epileptic seizures are symptoms of neurologic dysfunction and are but one manifestation of many neurologic diseases. Like any other syndrome in medicine, an epileptic syndrome is a group of signs and symptoms that share a common pathogenesis, prognosis, and response to treatment.
In 1989, the International League Against Epilepsy (ILAE) developed a classification of epileptic syndromes. A task force is revising this syndromic classification. The current system comprises 2 major categories: localization-related syndromes and generalized-onset syndromes. Physicians would ideally classify their patients' seizures by using the classification for seizure types and make a syndromic diagnosis if possible.
Localization-related epilepsies and syndromes include the following:
- Idiopathic, with age-related onset
- Benign childhood epilepsy with centrotemporal spikes
- Childhood epilepsy with occipital paroxysms
- Symptomatic
- Mesial temporal lobe sclerosis
Generalized epilepsies and syndromes include the following:
- Idiopathic, with age-related onset
- Benign neonatal familial convulsions
- Benign neonatal convulsions
- Benign myoclonic epilepsy of infancy
- Childhood absence epilepsy (pyknolepsy)
- Juvenile absence epilepsy
- Juvenile myoclonic epilepsy (JME)
- Epilepsy with grand mal seizures on awakening
- Idiopathic and/or symptomatic infantile spasms
- Lennox-Gastaut syndrome
- Epilepsy with myoclonic astatic seizures
- Epilepsy with myoclonic absences
- Symptomatic
In 2001, the Task Force on Classification and Terminology of the International League Against Epilepsy (ILAE) proposed that rather than revising the entire classifications of seizures (1981) or epilepsy syndromes (1989), a better strategy was to devise a 5-axis diagnostic scheme, as follows[16] :
- Axis 1: Descriptive ictal terminology
- Axis 2: Seizure type, from the “List of Epileptic Seizures” with specific brain location, if known
- Axis 3: Syndrome, from the “List of Epilepsy Syndromes,” not always possible
- Axis 4: Etiology, including specific genetic defects or pathologic substrates
- Axis 5: Impairment, optional but useful parameter can be derived from the World Health Organization (WHO) revised International Classification of Functioning, Disability and Health (ICIDH-2) impairment classification
The 2001 task force report also discussed the abandonment of the terms partial-onset or localization-related seizure or epilepsy for the term focal. The 2006 review of terminology formalized the change from partial to focal, but localization-related epilepsy remains an accepted term. In addition, the task force recommended that the term cryptogenic be replaced for the more precise wording of probably symptomatic. However, cryptogenic remains an accepted term.
Despite the fact that psychiatrists have successfully used for many years a somewhat similar 5-axis diagnostic scheme, critics indicate that this system is unnecessarily complex and its reliability, accuracy, and clinical use are uncertain. (For a more complete description of these controversies see Wolf [2003][17] and its discussion by Engel, Luders et al, Berg and Blackstone, and Avanzini. Similarly, see Fisher et al [2005][1] and its discussion).
To increase the controversy on this subject, there is evidence that epilepsy syndromes are not static diagnoses but ones that may evolve over time. They also have poor prognostic predictivity, and the interobserver reliability of classifying epileptic syndromes is poor.[18]
Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. Apr 2005;46(4):470-2. [Medline].
Goodkin HP. The founding of the American Epilepsy Society: 1936-1971. Epilepsia. Jan 2007;48(1):15-22. [Medline].
Rho JM, Sankar R, Cavazos JE. Epilepsy: Scientific Foundations of Clinical Practice. New York, NY: Marcel Dekker; 2004.
Houser CR, Esclapez M. Vulnerability and plasticity of the GABA system in the pilocarpine model of spontaneous recurrent seizures. Epilepsy Res. Dec 1996;26(1):207-18. [Medline].
Sloviter RS. Status epilepticus-induced neuronal injury and network reorganization. Epilepsia. 1999;40(suppl 1):S34-9; discussion S40-1. [Medline].
Scharfman HE, Schwartzkroin PA. Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science. Oct 13 1989;246(4927):257-60. [Medline].
Cavazos JE, Das I, Sutula TP. Neuronal loss induced in limbic pathways by kindling: evidence for induction of hippocampal sclerosis by repeated brief seizures. J Neurosci. May 1994;14(5 pt 2):3106-21. [Medline].
Sutula T, Cascino G, Cavazos J, et al. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol. Sep 1989;26(3):321-30. [Medline].
McCormick DA. Cellular mechanisms underlying cholinergic and noradrenergic modulation of neuronal firing mode in the cat and guinea pig dorsal lateral geniculate nucleus. J Neurosci. Jan 1992;12(1):278-89. [Medline].
Hosford DA, Clark S, Cao Z, et al. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science. Jul 17 1992;257(5068):398-401. [Medline].
Luders H, Acharya J, Baumgartner C, et al. Semiological seizure classification. Epilepsia. Sep 1998;39(9):1006-13. [Medline].
Loddenkemper T, Kellinghaus C, Wyllie E, Najm IM, Gupta A, Rosenow F. A proposal for a five-dimensional patient-oriented epilepsy classification. Epileptic Disord. Dec 2005;7(4):308-16. [Medline].
Engel J Jr. Report of the ILAE classification core group. Epilepsia. Sep 2006;47(9):1558-68. [Medline].
Wolf P. Basic principles of the ILAE syndrome classification. Epilepsy Res. Aug 2006;70 suppl 1:S20-6. [Medline].
Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009. Epilepsia. Apr 2010;51(4):676-85. [Medline].
Engel J Jr. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia. Jun 2001;42(6):796-803. [Medline].
Wolf P. Of cabbages and kings: some considerations on classifications, diagnostic schemes, semiology, and concepts. Epilepsia. Jan 2003;44(1):1-4; discussion 4-13. [Medline].
Beghi E. The concept of the epilepsy syndrome: how useful is it in clinical practice?. Epilepsia. May 2009;50 suppl 5:4-10. [Medline].
First Seizure Trial Group (FIR.S.T Group). Randomized clinical trial on the efficacy of antiepileptic drugs in reducing the risk of relapse after a first unprovoked tonic-clonic seizure. Neurology. Mar 1993;43(3 pt 1):478-83. [Medline].
[Best Evidence] Glauser TA, Cnaan A, Shinnar S, et al, for the Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. Mar 4 2010;362(9):790-9. [Medline].
Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA. Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. Oct 11 2011;77(15):1473-1481. [Medline].
[Best Evidence] Marson AG, Al-Kharusi AM, Alwaidh M, et al, for the SANAD Study group. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet. Mar 24 2007;369(9566):1016-26. [Medline].
Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med. Jul 18 1985;313(3):145-51. [Medline].
Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med. Sep 10 1992;327(11):765-71. [Medline].
[Best Evidence] Rowan AJ, Ramsay RE, Collins JF, et al, for the VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology. Jun 14 2005;64(11):1868-73. [Medline].
[Best Evidence] Marson AG, Al-Kharusi AM, Alwaidh M, et al, for the SANAD Study Group. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet. Mar 24 2007;369(9566):1000-15. [Medline].
French JA, Kanner AM, Bautista J, et al, for the Therapeutics and Technology Assessment Subcommittee of the AAN; Quality Standards Subcommittee of the AAN; and AES. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. Apr 27 2004;62(8):1252-60. [Medline].
French JA, Kanner AM, Bautista J, et al for the Therapeutics and Technology Assessment Subcommittee of the AAN; Quality Standards Subcommittee of the AAN; and AES. Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. Apr 27 2004;62(8):1261-73. [Medline].
[Guideline] Harden CL, Hopp J, Ting TY, et al, for the AAN and AES. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): I. Obstetrical complications and change in seizure frequency: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. May 2009;50(5):1229-36. [Medline].
[Guideline] Harden CL, Meador KJ, Pennell PB, et al, for the AAN and AES. Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. May 2009;50(5):1237-46. [Medline].
[Guideline] Harden CL, Pennell PB, Koppel BS, et al, for the AAN and AES. Management issues for women with epilepsy--focus on pregnancy (an evidence-based review): III. Vitamin K, folic acid, blood levels, and breast-feeding: Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Epilepsia. May 2009;50(5):1247-55. [Medline].
Kossoff EH, Turner Z, Bluml RM, Pyzik PL, Vining EP. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav. May 2007;10(3):432-6. [Medline].
[Best Evidence] Wiebe S, Blume WT, Girvin JP, Eliasziw M, for the Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. Aug 2 2001;345(5):311-8. [Medline].

